Maoris 10 mg/10 mg (Rosuvastatin and Ezetimibe)

Maoris is a prescription pharmaceutical product used for the treatment of high cholesterol, specifically combining two active ingredients: Rosuvastatin and Ezetimibe. The brand is part of the portfolio of Neopharmed Gentili, an established Italian pharmaceutical company.

Founded originally by the Gentili family and later becoming part of the Neopharmed group, the brand has deep roots in the Italian medical market. Today, the company is primarily owned by the private equity firms Ardian and NB Renaissance, which have invested heavily in the Italian healthcare sector to expand Neopharmed Gentili's reach. The product is primarily manufactured in Italy across various specialized pharmaceutical production sites.